C
Cristina Bulai Livideanu
Researcher at Paul Sabatier University
Publications - 62
Citations - 1231
Cristina Bulai Livideanu is an academic researcher from Paul Sabatier University. The author has contributed to research in topics: Medicine & Systemic mastocytosis. The author has an hindex of 15, co-authored 45 publications receiving 1024 citations. Previous affiliations of Cristina Bulai Livideanu include University of Strasbourg & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Corine Bertolotto,Fabienne Lesueur,Sandy Giuliano,Thomas Strub,Mahaut de Lichy,Karine Bille,Philippe Dessen,Benoit d’Hayer,Hamida Mohamdi,Audrey Remenieras,Eve Maubec,Arnaud de la Fouchardière,Vincent Molinié,Pierre Vabres,Stéphane Dalle,N. Poulalhon,Tanguy Martin-Denavit,Luc Thomas,Pascale Andry-Benzaquen,Nicolas Dupin,F. Boitier,Annick Rossi,Jean-Luc Perrot,Bruno Labeille,Caroline Robert,Bernard Escudier,Olivier Caron,Laurence Brugières,Simon Saule,Betty Gardie,Sophie Gad,Stéphane Richard,Jérôme Couturier,Bin Tean Teh,Paola Ghiorzo,Lorenza Pastorino,Susana Puig,Celia Badenas,Håkan Olsson,Christian Ingvar,Etienne Rouleau,Rosette Lidereau,Philippe Bahadoran,Philippe Vielh,Eve Corda,Hélène Blanché,Diana Zelenika,Pilar Galan,François Aubin,Bertrand Bachollet,Celine Becuwe,Pascaline Berthet,Yves-Jean Bignon,Valérie Bonadona,Jean -Louis Bonafe,Marie -Noelle Bonnet-Dupeyron,Frédéric Cambazard,Jacqueline Chevrant-Breton,Isabelle Coupier,Sophie Dalac,Liliane Demange,Michel D'Incan,Catherine Dugast,Laurence Faivre,Lynda Vincent-Fetita,Marion Gauthier-Villars,Brigitte Gilbert,Florent Grange,Jean-Jacques Grob,Philippe Humbert,Nicolas Janin,Pascal Joly,Delphine Kerob,Christine Lasset,Dominique Leroux,Julien Levang,Jean -Marc Limacher,Cristina Bulai Livideanu,Michel Longy,Alain Lortholary,Dominique Stoppa-Lyonnet,Sandrine Mansard,Ludovic Mansuy,Karine Marrou,Christine Mateus,Christine Maugard,Nicolas Meyer,Catherine Noguès,Pierre Souteyrand,Laurence Venat-Bouvet,Hélène Zattara,Valérie Chaudru,Gilbert M. Lenoir,Mark Lathrop,Irwin Davidson,Marie-Françoise Avril,Florence Demenais,Robert Ballotti,Brigitte Bressac-de Paillerets +98 more
TL;DR: A germline missense substitution in MITF (Mi-E318K) is identified that occurred at a significantly higher frequency in genetically enriched patients affected with melanoma, RCC or both cancers, when compared with controls and provides insights into the link between SUMOylation, transcription and cancer.
Journal ArticleDOI
Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study
Olivier Lortholary,Olivier Lortholary,Marie-Olivia Chandesris,Cristina Bulai Livideanu,Carle Paul,Gérard Guillet,Ewa Jassem,Marek Niedoszytko,Stéphane Barete,Srdan Verstovsek,Clive Grattan,Gandhi Damaj,Danielle Canioni,Sylvie Fraitag,Ludovic Lhermitte,Sophie georgin Lavialle,Laurent Frenzel,Lawrence B. Afrin,Katia Hanssens,Julie Agopian,Raphaël Gaillard,Jean-Pierre Kinet,Christian Auclair,Colin Mansfield,Alain Moussy,Patrice Dubreuil,Olivier Hermine +26 more
TL;DR: These study findings indicate that masitinib is an effective and well tolerated agent for the treatment of severely symptomatic indolent or smouldering systemic mastocytosis.
Journal ArticleDOI
In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells
Erinn Soucie,Katia Hanssens,Thomas Mercher,Sophie Georgin-Lavialle,Sophie Georgin-Lavialle,Gandhi Damaj,Cristina Bulai Livideanu,M.-O. Chandesris,Yolene Acin,Sébastien Letard,Paulo De Sepulveda,Olivier Hermine,Olivier Hermine,Olivier A. Bernard,Patrice Dubreuil +14 more
TL;DR: A oncogenic cooperation in mast cells is demonstrated and TET2 mutation is revealed as a potential marker to diagnose and predict severe forms of mastocytosis.
Journal ArticleDOI
ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
Gandhi Damaj,Magalie Joris,Olivia Chandesris,Katia Hanssens,Erinn Soucie,Danielle Canioni,Brigitte Kolb,Isabelle Durieu,Emanuel Gyan,Cristina Bulai Livideanu,Stéphane Cheze,Momar Diouf,Reda Garidi,Sophie Georgin-Lavialle,Vahid Asnafi,Ludovic Lhermitte,Christian Lavigne,David Launay,Michel Arock,Olivier Lortholary,Patrice Dubreuil,Olivier Hermine +21 more
TL;DR: Systemic mastocytosis with associated hematologic clonal non-mast cell disease (SM-AHNMD) is a rare and heterogeneous subtype of SM and few studies on this specific entity have been reported.
Journal ArticleDOI
Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.
Vivien Hébert,Claire Boulard,Estelle Houivet,Sophie Duvert Lehembre,Luca Borradori,Rocco della Torre,Claudio Feliciani,Luca Fania,Giovanna Zambruno,Diana B Camaioni,Biago Didona,Branka Marinović,Enno Schmidt,Nina Schumacher,Christian Hünefeld,Stefan Schanz,Johannes S. Kern,Silke C. Hofmann,Anne Charlotte Bouyeure,Catherine Picard-Dahan,Catherine Prost-Squarcioni,Frédéric Caux,Marina Alexandre,Saskia Ingen-Housz-Oro,Martine Bagot,E. Tancrede-Bohin,Jean-David Bouaziz,Nathalie Franck,Pierre Vabres,Bruno Labeille,Marie Aleth Richard,Emmanuel Delaporte,Alain Dupuy,Michel D'Incan,Gaëlle Quéreux,François Skowro,Carle Paul,Cristina Bulai Livideanu,Marie Beylot-Barry,Marie Sylvie Doutre,Martine Avenel-Audran,Christophe Bedane,Philippe Bernard,Laurent Machet,Hervé Maillard,Denis Jullien,Sébastien Debarbieux,Bruno Sassolas,Laurent Misery,C. Abasq,Olivier Dereure,Philippe Lagoutte,Vincent Ferranti,Victoria P. Werth,Dedee F. Murrell,Michael Hertl,Jacques Benichou,Pascal Joly +57 more
TL;DR: ABSIS and PDAI scores are robust tools to accurately assess pemphigus activity and their correlation with other severity markers in a large international study is confirmed.